Antonio Spadano

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · The Lancet · 2010 · 820 citations

Medicine, Hematology, Pharmacotherapy +17

Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome

Maria Antonietta Aloe Spiriti, Roberto Latagliata, Pasquale Niscola et al. · Annals of Hematology · 2004 · 110 citations

Medicine, Hematology, Pharmacology +7

Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.

Francesca Gay, Chiara Cerrato, Maria Teresa Petrucci et al. · Journal of Clinical Oncology · 2019 · 92 citations

Pharmacy, Oncology, Pharmacotherapy +9

Inositide-specific phospholipase c β1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia

Vincenza Rita Lo Vasco, G Calabrese, Lucia Manzoli et al. · Leukemia · 2004 · 60 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +10

Survival of elderly patients with acute myeloid leukemia.

Alessandro Pulsoni, Livio Pagano, Roberto Latagliata et al. · PubMed · 2004 · 59 citations

Medicine, Geriatric Medicine, Oncology +14